|Bid||1.2600 x 800|
|Ask||1.4900 x 900|
|Day's range||1.3050 - 1.4700|
|52-week range||1.1500 - 10.7900|
|Beta (5Y monthly)||2.42|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Investors need to pay close attention to Galera (GRTX) stock based on the movements in the options market lately.
The FDA bestows an Orphan Drug designation to Coherus (CHRS) and partner Junshi's toripalimab for the treatment of esophageal cancer.